BNP PARIBAS FINANCIAL MARKETS

Holdings History for Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

Symbol: APLS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	0%	$14,006,686	557,591	0		$25.12	Q4 2025
30 Sep 2025	0.02%	0%	$22,007,087	972,474	0		$22.63	Q3 2025
30 Jun 2025	0.02%	0%	$22,476,325	1,298,459	0		$17.31	Q2 2025
31 Mar 2025	0.02%	0%	$24,291,206	1,110,709	0		$21.87	Q1 2025
31 Dec 2024	0.02%	0%	$27,149,762	850,823	0		$31.91	Q4 2024
30 Sep 2024	0%	0%	$4,605,748	159,700	0		$28.84	Q3 2024
30 Jun 2024	0%	0%	$4,005,474	104,418	0		$38.36	Q2 2024
31 Mar 2024	0%	0%	$3,034,576	51,626	0		$58.78	Q1 2024
31 Dec 2023	0.02%	0%	$10,025,832	167,488	0		$59.86	Q4 2023
30 Sep 2023	0.02%	0%	$8,990,944	236,355	0		$38.04	Q3 2023
30 Jun 2023	0.01%	0%	$5,344,017	58,661	0		$91.10	Q2 2023
31 Mar 2023	0.02%	0%	$7,692,915	116,630	0		$65.96	Q1 2023
31 Dec 2022	0%	0%	$1,871,695	36,196	0		$51.71	Q4 2022
30 Sep 2022	0.02%	0%	$7,879,225	115,362	0		$68.30	Q3 2022
30 Jun 2022	0%	0%	$907,475	20,068	0		$45.22	Q2 2022
31 Mar 2022	0%	0%	$322,694	6,351	0		$50.81	Q1 2022
31 Dec 2021	0%	0%	$706,221	14,937	0		$47.28	Q4 2021
30 Sep 2021	0%	0%	$377,062	11,440	0		$32.96	Q3 2021
30 Jun 2021	0%	0%	$145,550	2,303	0		$63.20	Q2 2021
31 Mar 2021	0%	0%	$321,911	7,502	0		$42.91	Q1 2021
31 Dec 2020	0%	0%	$462,348	8,083	0		$57.20	Q4 2020
30 Sep 2020	0%	0%	$426,996	14,153	0		$30.17	Q3 2020
30 Jun 2020	0%	0%	$238,222	7,294	0		$32.66	Q2 2020
31 Mar 2020	0%	0%	$803,512	29,993	0		$26.79	Q1 2020
31 Dec 2019	0.01%	0%	$1,584,064	51,733	0		$30.62	Q4 2019
30 Sep 2019	0%	0%	$176,628	7,332	0		$24.09	Q3 2019
30 Jun 2019	0%	0%	$102,323	4,038	0		$25.34	Q2 2019
31 Mar 2019	0%	0%	$146,620	7,519	0		$19.50	Q1 2019
31 Dec 2018	0%	0%	$40	3	0		$13.33	Q4 2018
30 Sep 2018	0%	0%	$21,016	1,182	0		$17.78	Q3 2018
30 Jun 2018	0%	0%	$26,004	1,182	0		$22.00	Q2 2018
31 Mar 2018	0%	-0%	$43,225	1,955	-295	-13%	$22.11	Q1 2018
31 Dec 2017	0%	+0%	$48,825	2,250	+2,250	NEW	$21.70	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.